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Objectives. The aim of this study was to evaluate mast cell (MC) density and migration and their association with
matrix metalloproteinase (MMP) 9 expression in squamous cell carcinoma (SCC) and actinic cheilitis (AC).
Study design. Tryptase, c-Kit, and MMP-9 expression was evaluated in 20 cases of SCC, 20 cases of AC, and 7 cases
of normal lip (control samples) by immunohistochemistry techniques.
Results. Tryptase and c-Kit MC densities were significantly higher in SCCs than in ACs and control samples (P 
.001). However, no significant difference was found when comparing tryptase and c-Kit MC densities between ACs
and control samples (P values .185 and .516, respectively). MMP-9 was strongly expressed in SCCs and moderately
expressed in ACs and control samples. A highly significant association was found between tryptase MC density and
the expression of MMP-9 (P  .001).
Conclusions. The increase in MC density associated with the strong expression of MMP-9 may favor SCC
progression. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:342-348)Actinic cheilitis (AC) is a chronic inflammatory disor-
der that occurs mainly in the lower lip of middle-aged
men. It is usually caused by chronic and excessive
exposure of the lips to solar ultraviolet (UV) radia-
tion.1,2 The lesion is potentially malignant and may
transform into squamous cell carcinoma (SCC).3
Mast cells (MCs) are multifunctional cells that play
an important role in inflammation and have been asso-
ciated with both resistance and greater susceptibility to
tumor development.4,5 These cells are present in a large
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342number of tissues, including skin.6,7 MC prevalence in
human skin is modified by intrinsic (e.g., regulatory
mechanisms of c-Kit expression) and extrinsic factors
(e.g., chronic sun exposure).8,9
Matrix metalloproteinases (MMPs) are a family of
zinc- and calcium-dependent proteolytic enzymes that
degrade the extracellular matrix (ECM) constituents
and nonproteins.10 More than 20 different members are
currently known and was classified according to the
domain organization: collagenases (MMP-1, -8, -13,
and -18), gelatinases (MMP-2 and -9), stromelysins
(MMP-3 and -10), matrilysins (MMP-7, -26, and -11),
membrane-type MMPs (MMP-14, -15, -16, -17, -24,
and -25), and other MMPs (MMP-12, -19, -20, -21, -23,
-27, and -28). Among MMPs, gelatinase B (MMP-9)
plays an important role in angiogenesis as well as in
tumor invasion and metastasis, especially for its ability
to cleave type IV collagen in the basement mem-
brane.10-12 This gelatinase also cleaves other collagens,
such as types I, V, VII, and X, and substrates, such as
gelatin, fibronectin, tenascin-C, fibrillin, osteonectin,
decorin, 2-M, laminin-5, prointerleukin (IL) 1, pro–
tumor necrosis factor (TNF) , pro–transforming growth
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proteinase inhibitor and pro–MMP-1, -2, and -13.13
MMPs, including MMP-9, are generally synthesized
and secreted as latent soluble enzymes that require
activation in the extracellular space.14 They are regu-
lated at the transcription level, and their expression is
modulated by a variety of stimuli produced by cyto-
kines,15,16 growth factors,17 and cell-cell and cell-ma-
trix interactions.18-20 In addition, some studies have
also identified MCs derived from tryptase and chymase
as powerful MMP activators.21,22 The literature agrees
with the role of the stromal microenvironment in tu-
moral progression. Various experiments show evidence
of cooperation or synergy between neoplasic and stro-
mal cells in MMP production.23,24
The purpose of the present study was to evaluate MC
density and migration and their association to MMP-9
expression in AC and lip SCC to better understand the
role of MCs and MMP-9 in these lesions.
MATERIALS AND METHODS
We selected 20 cases of AC, 20 cases of SCC, and 7
cases of normal lip (used as control), all embedded in
paraffin, from the files of the Pathologic Anatomy
Service of the Oral Pathology Course, Dentistry Pro-
gram, Federal University of Rio Grande do Norte
(UFRN). For standardization purposes, selected cases
were microscopically examined by 2 independent ex-
aminers through the review of histologic sections
stained with hematoxylin and eosin. Histologic features
for AC included epithelial changes (keratosis, hyper-
Table I. Antibodies used
Antibody
clones Specificity Dilution Antigen retrieval Incubation
AA1* Tryptase 1:200 Citrate pH 6.0,
steamer
60 min










Table II. Immunoreactive scores used for analysis of
metalloproteinase 9 in lip squamous cell carcinoma,
actinic cheilitis, and normal lip
Score Percentage of immunopositive cells Staining intensity
0 0 Negative
1 10% Weakly positive
2 10%-50% Moderately positive
3 50% Strongly positivekeratosis, hyperplasia, atrophy, acanthosis, ulceration,and dysplasia) and connective tissue alterations (solar
elastosis and inflammation).1,3 Microscopic features for
SCC were analyzed according to the World Health
Organization tumor classification.2 The study was ap-
proved by the Institutional Review Board at UFRN.
Immunohistochemical methods
Paraffin-embedded tissues were sectioned (3 m)
and extended in glass slides coated with 2% 3-amino-
propyltriethoxy-silane (Sigma Chemical Co., St. Louis,
MO, USA). Sections were deparaffinized by immersion
in xylene, followed by immersion in alcohol with 3%
hydrogen peroxide to block endogenous peroxidase
activity, and then washed in Tris-buffered saline solu-
tion (TBS; pH 7.4). Antigen retrieval, incubation, dilu-
tion are shown in Table I. Sections were blocked by
incubation with 3% normal goat serum diluted in dis-
tilled water at room temperature for 20 minutes. Slides
were then incubated with the primary antibodies in a
humidified chamber. After washing in TBS, sections
were treated with labeled streptavidin-biotin kits
(K0690; Dako, Glostrup, Denmark) for tryptase and
MMP-9 and with the Envision system (K4001; system-
labeled polymer–horseradis peroxidase; DakoCytoma-
tion, Carpinteria, CA, USA) for c-Kit. We used 0.03%
diaminobenzidine (DAB; Sigma, Chemical Co.) as
chromogen, and counterstaining was performed with
Mayer hematoxylin. Positive control samples for tryp-
tase, c-Kit, and MMP-9 were, respectively, sections of
lung, gastrointestinal stromal tumor, and liver. As neg-
ative control subjects, samples were treated as above,
except that the primary antibody was replaced by a
solution of bovine serum albumin in phosphate-buff-
ered saline solution.
Immunohistochemical expression of MC
evaluation
Tryptase– and c-Kit–immunoreactive MC counting
was performed with the aid of a graticule coupled to an
optical microscope (CX31; Olympus, Tokyo, Japan).
The number of immunomarked MCs for each antibody
was separately determined for each group in histologic
fields of higher density. Two previously calibrated and
independent observers performed MC counting in 10
fields of control cases (5 fields at the epithelium–con-
nective tissue junction and 5 in the reticular lamina
propria), in 10 fields of ACs (5 at the epithelium–
connective tissue junction and 5 in areas of solar elas-
tosis), and in 15 fields of SCCs (5 at the epithelium–
connective tissue junction, 5 in the tumor parenchyma,
and 5 in the peritumoral stroma), at 400 magnifica-
tion (counting field area 0.20 mm2).
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evaluation
MMP-9 immunohistochemical staining was evaluated
through descriptive and semiquantitative analysis. In the
latter, we used scores adjusted from Franchi et al.25 for
analysis of the epithelial tissue in ACs and control sam-
ples and of tumor cells in SCCs, based on the percentage
of immunoreactive cells and their staining intensity (Table
II). The analysis was performed using a light microscope
by 2 previously calibrated and independent observers.
Statistical analyses
MC density descriptive analysis was expressed as con-
fidence intervals (CIs) of the number of observations per
mm2. Comparative analysis of means between groups and
between histologic fields was performed using parametric
1-way analysis of variance (ANOVA). Paired multiple
comparisons were then performed by using the Tukey test.
MC migration was expressed as the ratio between c-Kit
and tryptase densities, and the comparative analysis be-
tween groups was performed with 1-way ANOVA and
Tukey post hoc tests. Association between MC density
and MMP-9 expression was assessed by using the Student
t test. Differences were considered to be statistically sig-
nificant when P  .05.
RESULTS
The main histologic findings regarding the 20 speci-
Table III. Distribution of main histologic findings of
the 20 specimens of actinic cheilitis





Epithelial atrophy 13 65
Solar elastosis 20 100




Table IV. Tryptase and c-Kit mast cell (MC) den-
sities in lip squamous cell carcinoma (SCC), actinic







(95% CI) P value†
SCC 20 181.173-246.327 75.551-110.322) .001
AC 20 53.727-77.073 51.089-68.111
Control 7 19.583-34.702 12.345-69.083
CI, Confidence interval.
†Analysis of variance.
*Number of positive cells/mm2.mens of ACs are summarized in Table III. In the SCCanalysis, 7 cases were classified as well differentiated, 3 as
moderately differentiated, and 10 as undifferentiated.
Resident MCs were identified by the use of antitryptase
antibody, and MC migration was evaluated with an anti–
c-Kit antibody. Analysis of material submitted to immu-
nohistochemistry showed that tryptase MCs were more
strongly expressed in SCCs than in ACs and control
samples (P  .001 [Tukey post hoc test]; Table IV). In
these tumors, a significantly high density of tryptase
MCs was found in the tumor stroma, surrounding the
invasive epithelial nests and cords (Fig. 1, a). A high
expression of these cells was also observed near the lining
epithelium adjacent to the tumor, though less than in the
stroma (P .007 [Tukey]). Moreover, a sparse density of
these cells was observed in the lesion parenchyma com-
pared with the tumor stroma (P  .001 [Tukey]).
Regarding the immunostaining for c-Kit, we found a
higher concentration of c-Kit MCs in SCCs than in ACs
and control samples (P .001 [Tukey]; Table IV), similar
to what was found for tryptase. A higher c-Kit MC
density was also found in the tumor stroma (Fig. 1, b) and
at the epithelium–connective tissue junction compared
with the tumor parenchyma (P  .001 [Tukey]).
In the analyzed ACs, tryptase and c-Kit MCs were
present in areas of elastosis and near the epithelium/
connective tissue junction (Fig. 1, c and d), but the dif-
ference was not significant in the expression of these
markers between these regions (P values .195 and .496,
respectively).
In specimens of normal lip, used as the control
group, lower tryptase and c-Kit MC densities were
observed. These cells were mainly located in the epi-
thelium/connective tissue junction and in the reticular
lamina propria (Fig. 1, e and f), but the difference was
not significant in the expression of these markers be-
tween these regions (P values .165 and .626, respec-
tively). Nonetheless, no significant difference was
found when comparing tryptase and c-Kit MC den-
sities between ACs and control samples (P values .185
and .516, respectively [Tukey]).
MC migration (c-Kit–tryptase relationship) was
75% in SCCs, 103% in ACs, and 138% in control
samples. When the MC migration was compared be-
tween lesions, the difference was significant only be-
tween SCCs and control samples (P  .012) and not
between SCCs and ACs (P  .166) nor between ACs
and control samples (P  .231).
All SCC specimens exhibited strong expression of
MMP-9 in tumor nests (Fig. 2, a). Expression of this
gelatinase was also observed in inflammatory and endo-
thelial cells. All AC cases showed a moderate MMP-9
expression, which was heterogeneously evident in the
epithelium. Staining was generally negative in the epithe-
lial surface layers (Fig. 2, b). MMP-9 also showed mod-
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in most of the epithelium, although it was occasionally
negative in focal areas of keratinized, granular and prickle
layers (Fig. 2, c). A highly significant association was
found between the tryptase MC density and the expres-
sion of MMP-9 (P  .001; Table V).
DISCUSSION
MCs are multipotent hematopoietic progenitor cells
that circulate through blood vessels and subsequently mi-
grate to peripheral tissues where they undergo terminal
differentiation and participate in regulating the immune
response. The migration process is influenced by the stem
cell factor (SCF), also known as MC growth factor, and
Fig. 1. Tryptase and c-Kit mast cell immunoexpression
normal lip (control). Tryptase (a) and c-Kit (b) mast cel
c-Kit (d) mast cell immunoexpression in solar elastosis regio
in epithelium–connective tissue junction and lamina propria
original magnification 200).the local microenvironment.9,26 These cells play a varietyof roles. Besides acting in the innate and acquired immune
response, they are also able to degrade the ECM. MC
degranulation releases specific products, such as tryptase,
chymase, MMPs, basic fibroblast growth factor, heparin,
histamine, TNF-, various interleukins (IL-3, -4, -5, -6,
-8, -10, -13, and -16), chemokines (MCP-1/CCL2, MIP-
1/CCL3, MIP-1/CCL4 and RANTES/CCL5), and lip-
idic mediators.5,27-30 Of these, tryptase is the most abun-
dant serine proteinase stored in MC granules.29 It
promotes inflammation, ECM destruction, and tissue re-
modeling31,32 and is considered to be an important angio-
genic factor.33
The results of the present study showed a significant
increase of tryptase MCs in SCCs compared with
squamous cell carcinoma (SCC), actinic cheilitis (AC), and
noexpression in stromal region of SCC. Tryptase (c) and
C. Tryptase (e) and c-Kit (f) mast cell immunoexpression
n of control (Strept avidin biotin complex [SABC] method,in lip
l immu
n of A
regionormal lip. These findings agree with other results in
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al.36 found a decrease of tryptase MCs in oral squa-
Fig. 2. MMP-9 immunoexpression in lip squamous cell carci-
noma (SCC), actinic cheilitis (AC), and normal lip (control). A,
Immunoexpression in tumor nests of SCC. B, Immunoexpres-
sion in epithelium of AC. C, Immunoexpression in epithelium of
control (SABC method, original magnification 400).mous cell carcinoma (OSCC) and leukoplakia. Studieshave pointed to an increase in the number of MCs,
including tryptase ones, in solar radiation–exposed
skin.9,37-40 This may explain the differences in MC
densities found in SCCs and ACs compared with OS-
CCs. Chronic exposure to radiation, particularly UV,
has been described as one of the main risk factors
related to AC and SCC development.35,40
Our results also showed a significant increase of
tryptase MCs in SCCs compared with ACs, unlike the
findings of Costa et al.,34 where similar MC densities
were found in both lesions. ACs present a variety of
histologic changes that primarily include varying de-
grees of keratosis, solar elastosis, epithelium atrophy or
hyperplasia, and the absence or presence of dysplasia.1
All cases studied by Costa et al. were classified as mild
epithelial dysplasia, whereas in our study only 5 cases
were so classified. That may explain the different MC
densities observed in ACs between these studies.
In the present study, a higher MC density was observed
in the stroma compared with the tumor parenchyma. MCs
may accumulate in the stroma around the tumor and take
part in the inflammatory reaction that happens at the tumor
edge and in the local tumor immunity.5 Nevertheless, the
increase of stromal tryptase MCs has also been reported
as an important factor for tumor invasion on cancers in
various anatomic sites.41,42 Therefore, these cells may
contribute to the defense against tumors as well as to their
progression.
Our results also pointed to a significant increase in
c-Kit MC density in SCCs and ACs compared with
control samples. These findings differ from the results
of Costa et al.34 who found a similar cell density for the
3 groups. c-Kit (CD 117) is a transmembrane receptor
tyrosine kinase type III that acts in cellular signal
transduction in various cell types. It is usually activated
by binding to its ligand, stem cell factor (SCF). In this
scenario, it promotes phosphorylation and activation of
the intracytoplasmic signaling cascade which is essential
for embryogenesis, hematopoiesis, development, prolifer-
ation, and migration. c-Kit is expressed in normal human
tissue, melanocytes, breast epithelium, interstitial cells
of Cajal, and MCs. SCF stimulates directional motility
Table V. Tryptase mast cell (MC) density and met-





(mean 	 SD) P value†
27 Moderate 55.48 	 27.60 0.001
20 Strong 213.75 	 69.61
*Number of positive cells/mm2.
†Student t test.of both mucosal and connective tissue–type MCs. It
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up-regulation of TNF-, chemokine production, and
the induction of histamine release.43
MCs are long-lived cells that can restart the cell
cycle, proliferate, and be recruited after an appropriate
stimulation. This stimulus may contribute to population
expansion of these cells. Kim et al.9 suggest that the
stimuli derived from sunlight (either UV or infrared) or
heat may act as extrinsic factors in regulating MC
quantity and distribution in human skin. These authors
postulate that these cells are recruited to sites of irra-
diated skin by several mechanisms. Ultraviolet or in-
frared radiation may both directly and indirectly stim-
ulate MC proliferation in human skin. Indirect
stimulation happens through keratinocytes or fibro-
blasts that can produce and release chemotactic factors
for MCs. These factors recruit and activate inflamma-
tory cells to sites of irradiated skin. Thus, MCs can
migrate due to chemotactic factors, such as SCF,
TGF-, vascular endothelial growth factor, and IL-8.
On the other hand, other authors also point out that
tryptase/chymase MCs can promote ECM degradation
and tumor progression at the invasive front in SCCs.
Earlier studies suggest that tryptase has the ability to
contribute to the process of tissue remodeling through
pro–MMP-1, -2, -3, and -9 activation.22,44-46 Tryptase
may indirectly act in ECM degradation, activating latent
forms of MMPs, as well as directly, degrading substrates
such as collagens type I and IV and fibronectin.22,38,46
Prolonged exposure to UV radiation in the normal
process of aging may also enable pro-MMPs, leading to
ECM degradation.47 A study reported a possible link
between exposure to UV radiation and the degradation
of the basement membrane by gelatinases.48
MMPs mediate tumor angiogenesis, malignant trans-
formation, proliferation, and apoptosis through the deg-
radation of the basement membrane, of cell adhesion
molecules, and several matrix components and through
the activation of chemokines and growth factors.49
MMP-9 overexpression has been associated with tu-
mors in various anatomic sites25,50,51 as well as with
tumor progression and skin metastasis.10,11 A highly
significant difference was observed in the present study
between tryptase and c-Kit MC densities and
MMP-9 expression. MMP-9 was strongly expressed
both in tumor cells and in stromal inflammatory and
endothelial cells. These findings agree with earlier stud-
ies.52,53 Inflammatory stimulation may induce MMP-9
expression in various cells, such as endothelial cells,
macrophages, fibroblasts, and MCs.11
The high tryptase MC density observed in our study
in SCCs may be related to the stimulus produced by sun
exposure. This exposure may contribute to MC prolifera-
tion at irradiated sites. In the present study, MC migrationdid not differ in SCC compared with control samples, as
shown by the c-Kit/tryptase ratio. The strong MMP-9
expression observed in SCCs suggests that tryptase MCs
present in these lesions may take part in ECM degradation
and tumor progression by means of activating this gelati-
nase. Furthermore, tryptase MCs, predominantly located
in the stroma, are also important for angiogenic stimula-
tion, which is essential for growth and survival of tumor
cells. Therefore, we may conclude that the increase in MC
density in SCCs suggests that these cells, associated with
MMP-9 expression, may contribute to the progression of
these tumors.
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